Business Wire

ZEDRA Announces Milestone Acquisition of Global Expansion Specialist Fitzgerald & Law.

14.9.2020 10:00:00 EEST | Business Wire | Press release

Share

ZEDRA, the fast growing global specialist in Corporate, Fund and Active Wealth Solutions has announced the acquisition of Fitzgerald & Law (F&L), London’s leading firm of global expansion advisers. In addition to offering a wide range of specialised expansion advice to companies setting up in the UK, F&L provides a full suite of award-winning tax, HR and financial compliance services that supports those companies as they grow. At the same time as this transaction, ZEDRA will acquire the Global Expansion Advisory Network operating in over 70 countries, of which F&L is a founding firm. F&L’s continued membership of the GEA Network means that companies expanding into countries other than the UK can receive the same unparalleled support.

This acquisition marks a step change for ZEDRA’s corporate services offering and will substantially enlarge the Group’s reach to fast-growing US technology companies. F&L has a particular focus on helping US companies wishing to establish and grow a UK presence, and more broadly advises companies from all over the world on expanding their footprint in other territories globally. F&L has a strong track record in multi-territory HR consulting, international tax compliance, corporate compliance and accounting services.

The acquisition will bolster ZEDRA’s presence in the all-important London market with F&L’s London team of over 70 helping to double ZEDRA’s workforce in the UK. ZEDRA also welcomes a team of 14 in Romania who provide vital support to the outsourcing services function. The F&L San Francisco office will continue to play a key role in business development and supporting clients on the US West Coast.

Ivo Hemelraad, ZEDRA Chief Executive Officer, commented, “We are delighted to welcome the employees and clients of Fitzgerald & Law to ZEDRA and to extend our corporate services reach to the US West Coast where F&L has an enviable and growing reputation. Adding their knowledge and expertise to our Group will significantly extend the support we can offer to our international corporate clients and help them optimise their global expansion strategies.”

Gabriel Parrish, Senior Partner at F&L added, “Joining ZEDRA at this time with its global footprint of offices and international client base is a natural fit for F&L, and a logical step forward in our growth plans. Our clients will now have access to an additional range of services to support their business ambitions.”

Fitzgerald & Law will ultimately rebrand to ZEDRA.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media enquiries :

https://www.zedra.com/boilerplate/

Guy Stephenson
Nacelle
Tel: +44 20 8333 9125

Fitzgerald & Law

Kirstie Leadley
+44 (0)7988 719736
kleadley@fitzandlaw.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme

EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release

European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea

ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants

NIQ Brings New AI and Automation Capabilities to Retail Space Planning and Merchandising2.10.2026 13:45:00 EEST | Press release

NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced new AI and automation capabilities for NIQ Spaceman®, its retail space planning and merchandising platform trusted by more than 600 retailers across 65+ countries. The enhancements help retailers create store-specific planograms up to 50 times faster, identify execution and compliance gaps, and scale merchandising decisions across their store networks through expanded cloud-based access. "Retailers are under increasing pressure to localize assortments, execute consistently across stores, and respond more quickly to changing shopper behavior," said Natalie Williams, SVP, Product at NIQ. "These enhancements help simplify that process by embedding agentic AI directly into merchandising workflows and automating traditionally manual planning tasks. That means teams can spend less time building and updating planograms and more time acting on opportunities. With greater automation, retailers can improve productivi

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2.10.2026 13:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to one senior leader and ten newly hired non-executive employees. The equity awards for the senior leader were granted on September 30, 2026 and consisted of options to purchase an aggregate of 121,800 shares and restricted share units covering an aggregate of 58,000 shares. The options have an exercise price per share equal to $12.44. The equity awards to the ten newly hired non-executive employees were granted on October 1, 2026 and consisted of options to purchase an aggregate of 97,100 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 46,200 shares. These options have an exercise price per share equal to $11.95, the closing price of the Company’s American De

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye